Evidence map›Paper›PMID 40427045›Full record

ArticleBiomedicines2025

Human and Mouse Bone Marrow CD45

Roman Perik-Zavodskii, Olga Perik-Zavodskaia, Julia Shevchenko, Kirill Nazarov, Anastasia Gizbrekht, Saleh Alrhmoun, Vera Denisova, Sergey Sennikov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roman Perik-ZavodskiiLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.ORCID 0000-0002-5055-4859
Olga Perik-ZavodskaiaLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.ORCID 0000-0003-4911-1994
Julia ShevchenkoLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.
Kirill NazarovLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.ORCID 0000-0001-7175-4051
Anastasia GizbrekhtLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.
Saleh AlrhmounLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.ORCID 0000-0003-0788-5385
Vera DenisovaClinic of Immunopathology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.
Sergey SennikovLaboratory of Molecular Immunology, Research Institute of Fundamental and Clinical Immunology, Novosibirsk 630099, Russia.ORCID 0000-0002-7366-7768

Funding

Russian Science Foundation 25-25-00339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibacterial immunitycalprotectinCD45+ erythroid cellserythroid cellslipopolysaccharideLPS

Identifiers

PMID40427045
PMCPMC12108605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.